JP2024529434A5 - - Google Patents
Info
- Publication number
- JP2024529434A5 JP2024529434A5 JP2024504774A JP2024504774A JP2024529434A5 JP 2024529434 A5 JP2024529434 A5 JP 2024529434A5 JP 2024504774 A JP2024504774 A JP 2024504774A JP 2024504774 A JP2024504774 A JP 2024504774A JP 2024529434 A5 JP2024529434 A5 JP 2024529434A5
- Authority
- JP
- Japan
- Prior art keywords
- score
- antibody
- pharmaceutical composition
- subject
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163225716P | 2021-07-26 | 2021-07-26 | |
| US63/225,716 | 2021-07-26 | ||
| US202163240734P | 2021-09-03 | 2021-09-03 | |
| US63/240,734 | 2021-09-03 | ||
| US202263313041P | 2022-02-23 | 2022-02-23 | |
| US63/313,041 | 2022-02-23 | ||
| EP22315049 | 2022-03-04 | ||
| EP22315049.1 | 2022-03-04 | ||
| US202263353654P | 2022-06-20 | 2022-06-20 | |
| US63/353,654 | 2022-06-20 | ||
| PCT/US2022/038185 WO2023009437A1 (en) | 2021-07-26 | 2022-07-25 | Methods for treating chronic spontaneous urticaria by administering an il-4r antagonist |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024529434A JP2024529434A (ja) | 2024-08-06 |
| JP2024529434A5 true JP2024529434A5 (cg-RX-API-DMAC10.html) | 2025-08-01 |
Family
ID=82899210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024504774A Pending JP2024529434A (ja) | 2021-07-26 | 2022-07-25 | Ｉｌ－４ｒアンタゴニストを投与することによる慢性自発性蕁麻疹を治療するための方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230146317A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4377345A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024529434A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20240037321A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2022316939A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3226781A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL310362A (cg-RX-API-DMAC10.html) |
| MX (1) | MX2024001189A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023009437A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102502640B1 (ko) | 2012-08-21 | 2023-02-23 | 사노피 바이오테크놀로지 | Il-4r 길항제의 투여에 의한 천식의 치료 또는 예방 방법 |
| IL315136A (en) | 2014-02-21 | 2024-10-01 | Sanofi Biotechnology | Methods for treating or preventing asthma by administering an il-4rantagonist |
| CA3246946A1 (en) | 2014-11-14 | 2025-11-29 | Sanofi Biotechnology | Methods for treating chronic sinusitis with nasal polyps by administering an il-4r antagonist |
| KR20220034878A (ko) | 2019-07-16 | 2022-03-18 | 사노피 바이오테크놀로지 | Il-4r 길항제를 투여하여 천식을 치료 또는 예방하는 방법 |
| CN122055788A (zh) * | 2023-10-24 | 2026-05-15 | 赛诺菲 | 用于监测药剂给药时间表的系统和方法 |
| KR20250118250A (ko) * | 2024-01-26 | 2025-08-06 | 연세대학교 산학협력단 | 식물에서 발현된 항-IL-4Rα 항체의 항원결합 단편 및 이의 용도 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6927044B2 (en) | 1998-09-25 | 2005-08-09 | Regeneron Pharmaceuticals, Inc. | IL-1 receptor based cytokine traps |
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| US8178098B2 (en) | 2001-04-03 | 2012-05-15 | National Jewish Health | Method to inhibit airway hyperresponsiveness using aerosolized T cell receptor antibodies |
| ATE537190T1 (de) | 2006-06-02 | 2011-12-15 | Regeneron Pharma | Hochaffine antikörper gegen den humanen il-6- rezeptor |
| US7608693B2 (en) | 2006-10-02 | 2009-10-27 | Regeneron Pharmaceuticals, Inc. | High affinity human antibodies to human IL-4 receptor |
| CA2664343C (en) | 2006-10-02 | 2016-04-26 | Regeneron Pharmaceuticals, Inc. | High affinity human antibodies to human il-4 receptor |
| US8092804B2 (en) | 2007-12-21 | 2012-01-10 | Medimmune Limited | Binding members for interleukin-4 receptor alpha (IL-4Rα)-173 |
| MX366337B (es) | 2010-10-06 | 2019-07-05 | Regeneron Pharma | Formulaciones estabilizadas que contienen anticuerpos anti-receptor de interleucina-4 (il-4r). |
| TWI755763B (zh) * | 2013-06-04 | 2022-02-21 | 美商再生元醫藥公司 | 藉由投與il-4r抑制劑以治療過敏及增強過敏原-特異之免疫療法的方法 |
| CN107474134B (zh) | 2016-06-08 | 2021-07-27 | 苏州康乃德生物医药有限公司 | 用于结合白细胞介素4受体的抗体 |
| KR102330596B1 (ko) | 2018-11-09 | 2021-11-26 | 아주대학교산학협력단 | 인간 il-4 수용체 알파에 대한 고친화도 인간 항체 및 이의 용도 |
| KR20210143246A (ko) * | 2019-03-21 | 2021-11-26 | 리제너론 파아마슈티컬스, 인크. | 알레르기 치료용 il-4/il-13 경로 억제제 및 형질 세포 절제의 병용 |
-
2022
- 2022-07-25 AU AU2022316939A patent/AU2022316939A1/en active Pending
- 2022-07-25 IL IL310362A patent/IL310362A/en unknown
- 2022-07-25 MX MX2024001189A patent/MX2024001189A/es unknown
- 2022-07-25 CA CA3226781A patent/CA3226781A1/en active Pending
- 2022-07-25 KR KR1020247006130A patent/KR20240037321A/ko active Pending
- 2022-07-25 US US17/872,225 patent/US20230146317A1/en active Pending
- 2022-07-25 WO PCT/US2022/038185 patent/WO2023009437A1/en not_active Ceased
- 2022-07-25 JP JP2024504774A patent/JP2024529434A/ja active Pending
- 2022-07-25 EP EP22754671.0A patent/EP4377345A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| de Oliveira Rocha et al. | Thoracic sympathetic block for the treatment of complex regional pain syndrome type I: a double-blind randomized controlled study | |
| Foss et al. | Fascia iliaca compartment blockade for acute pain control in hip fracture patients: a randomized, placebo-controlled trial | |
| Mitchell et al. | A single infusion of intravenous ketamine improves pain relief in patients with critical limb ischaemia: results of a double blind randomised controlled trial | |
| RU2012117563A (ru) | Режим дозирования модулятора рецептора s1p | |
| Chen et al. | Oral diazepam versus intravenous midazolam for conscious sedation during cataract surgery performed using topical anesthesia | |
| KR20150003765A (ko) | 라퀴니모드와 디메틸 푸마레이트의 병용물에 의한 다발성 경화증의 치료 | |
| CN104602689A (zh) | 生物素治疗多发性硬化的用途 | |
| AU2025203339A1 (en) | Therapeutic Uses of Tirzepatide | |
| JP2015522077A (ja) | ラキニモドおよびファムプリジンの組合せによる多発性硬化症の治療 | |
| CN119421702A (zh) | 替尔泊肽组合物和用途 | |
| JP2025072354A (ja) | チルゼパチド治療方法 | |
| Cohen | Emerging therapies for relapsing multiple sclerosis | |
| KR20170131543A (ko) | 근위축성 측삭 경화증을 치료하기 위한 비오틴 | |
| US20070225368A1 (en) | Therapy for Multiple Sclerosis | |
| TW201211021A (en) | Methods of use of cyclic amide derivatives to treat schizophrenia | |
| Marcon et al. | Effects of ganglioside G (M1) and erythropoietin on spinal cord lesions in rats: functional and histological evaluations | |
| Harned et al. | An introduction to trialing intrathecal baclofen in patients with hemiparetic spasticity: a description of 3 cases | |
| Fryman et al. | Guillain-Barré syndrome induced dysautonomia resulting in cardiac arrest | |
| MEYER et al. | Influence of norethynodrel with mestranol on intraocular pressure in glaucoma: II. A controlled double-blind study | |
| Ryan et al. | Providing pharmaceutical care to the multiple sclerosis patient | |
| JP4775940B2 (ja) | アロディニアの治療、改善、予防剤 | |
| Shankar et al. | Ayurvedic management of neurological deficits post COVID-19 vaccination-A report of two cases | |
| Cheesman | Sickle cell disease: symptoms, complications and management | |
| Yazbeck-Karam et al. | Supplementation of retrobulbar block with clonidine in vitreoretinal surgery: effect on postoperative pain | |
| RU2024104460A (ru) | Способы лечения хронической спонтанной крапивницы путем введения антагониста il-4r |